Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7448 p456-457
21 April 2007

This article
Reprint   Photocopy

PDF 70K, Acrobat Reader

Letters

• White Paper (5)
• Pseudoephedrine (2)
• Eczema
• Chemotherapy
• Community pharmacy (2)
• Locum pharmacy
• Packaging
• Dispensing
• MDS
• Parallel imports
• Prescription charges
• The Society
• Skill mix
• Professionalism
• Boots travel insurance


Letters to the Editor

Eczema

Patient and carer knowledge of skin preparations

From Dr R. Woodford, MRPharmS

Increasing attention is being paid by health care professionals and parents to the management of childhood eczema, and the investigation by Alison Carr and colleagues (PJ, 17 March, pp319–22) is timely and exciting. With a variety of bath additives, shower gels, emollient creams and ointments augmented by topical steroids of differing potencies, a wide range of preparations is available. Perhaps it is not too surprising that parents may have unwarranted concerns and a poor understanding of the correct use of dermatological products.

Woodford et al1 found that the parents of 26 children (aged five years or under) who used hydrocortisone cream scored highest on both knowledge of preparation and potential side effects of topical steroids, but exhibited the greatest “steroid phobia” in a study of 203 patients and carers in 10 age brackets that were prescribed corticosteroids. These parents also had little apparent knowledge of the relative value of moisturisers or steroids in the management of their child’s eczema. In most cases, the intended mode of emollient application was questionable (insufficient quantity, infrequent application, concomitant use of hydrocortisone cream).

An unpublished 18-month audit conducted in the same pharmacy of persons seeking advice on their skin condition was presented 10 years ago to the Primary Care Dermatology Society.2 Of the 714 initial consultations, 26 per cent were diagnosed as eczema or dermatitis and 15 per cent were dry skin conditions. Of the 2,782 prescriptions for dermatological preparations dispensed during that audit period, 31 per cent were for emollients. Elements of that work were accepted as evidence in the 2000 “Report on the enquiry into skin diseases in elderly people” published by the Associate Parliamentary Group on Skin. With an aging population suffering dry skin and with the continuing misery of childhood eczema, the use of skin moisturisers is set to increase. Continuing education for patients and their carers regarding the use of several preparations in “complete emollient therapy” is an important role for pharmacists and confusion regarding the use of “wash-off” and “leave-on” emollients may well exist. Dr Carr and the community pharmacists involved in her study are to be congratulated on their conscientious approach. Their paper deserves a wide readership.

Roger Woodford
Portsmouth


References

1. Woodford R, Woodford EM, Langley CA, Marriott JF, Wilson KA. Patient knowledge and acceptability of topical corticosteroid preparations: the role of the pharmacist in patient education. International Journal of Pharmacy Practice 2001;9(Suppl):R38 (PDF 40K)

2. Woodford R. Responding to patients and their symptoms in a village community pharmacy — dermatological presentations. Paper presented at the Primary care Dermatology Society Annual Meeting, Harrogate, 1997.

Send your letter to The Editor

Previous Topic (Pseudoephedrine)
Next Topic (Chemotherapy)

Back to Top


©The Pharmaceutical Journal